PIK3CA and esophageal squamous cell carcinoma: In line with these findings, a similar report was conducted in ESCC by Song B et al. [85], in which data from 104 patients with ESCC were collected; the authors found that ESCC patients with mutations in PIK3CA had longer survival times than those without PIK3CA mutations.